View in EDS

Defining regorafenib as a senomorphic drug: therapeutic potential in the age-related lung disease emphysema.

Saved in:
Bibliographic Details
Title: Defining regorafenib as a senomorphic drug: therapeutic potential in the age-related lung disease emphysema.
Authors: Park JJ; Department of Biochemistry, Chungbuk National University College of Medicine, Cheongju, 28644, Korea., Oh K; Department of Biochemistry, Chungbuk National University College of Medicine, Cheongju, 28644, Korea., Lee GW; Department of Biochemistry, Chungbuk National University College of Medicine, Cheongju, 28644, Korea., Bang G; Research Center for Bioconvergence Analysis, Korea Basic Science Institute, Ochang, 28119, Korea., Park JH; Department of Biochemistry, Chungbuk National University College of Medicine, Cheongju, 28644, Korea., Kim HB; Department of Biochemistry, Chungbuk National University College of Medicine, Cheongju, 28644, Korea., Kim JY; Research Center for Bioconvergence Analysis, Korea Basic Science Institute, Ochang, 28119, Korea., Shin EY; Department of Biochemistry, Chungbuk National University College of Medicine, Cheongju, 28644, Korea. eyshin@chungbuk.ac.kr., Kim EG; Department of Biochemistry, Chungbuk National University College of Medicine, Cheongju, 28644, Korea. egkim@chungbuk.ac.kr.
Source: Experimental & molecular medicine [Exp Mol Med] 2023 Apr; Vol. 55 (4), pp. 794-805. Date of Electronic Publication: 2023 Apr 03.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 9607880 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2092-6413 (Electronic) Linking ISSN: 12263613 NLM ISO Abbreviation: Exp Mol Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2092-6413
DOI:10.1038/s12276-023-00966-6